Dr. Rizvi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7031 Southwest 62nd Avenue
South Miami, FL 33143Phone+1 305-284-7500
Summary
- A broadly trained physician scientist, educator, and healthcare provider with vast Clinical and Translational Research experience driving innovation within pharmaceutical product development platforms. Highly motivated and committed to advancing medical innovation, discovering new therapies, improving patient outcomes, and playing an instrumental role in scientific and business strategies. Equipped with diverse academic background and over 26 years of combined experience in academia, administrative, and healthcare settings.
Education & Training
- Harvard UniversityCertificate, Foundations of Clinical Research, 2022 - 2022
- University of Science, Arts and TechnologyMPH, Health Care Management, 2020 - 2022
- University of Science, Arts and TechnologyClass of 2022
- Cornell UniversityCertificate, Certificate in Executive Leadership, 2012 - 2013
- Aspen UniversityMBA, Pharmaceutical Marketing and Management, 2011 - 2012
- Mercer UniversityPhD, Pharmaceutical Sciences, 2006 - 2010
- Emory UniversityPostdoctorate, Organic and Surface Chemistry, Self-aggregating Systems, Soft Materials, 2006 - 2009
- Georgia State UniversityPhD, Analytical and Organic Chemistry, 2001 - 2006
Certifications & Licensure
- FL State Medical License 2022 - 2026
- Vascular Access Certification CorporationVascular Access Board Certified (VA-BC)
Awards, Honors, & Recognition
- Fellow of the Royal Society of Medicine (FRSM) Royal Society of Medicine
Clinical Trials
- Study of SPX-101 in Subjects With Advanced or Refractory Solid Tumors Start of enrollment: 2022 Apr 01
Publications & Presentations
PubMed
- Improving allergy management and treatment: a proposed algorithm and curriculum for prescribing allergen immunotherapy in the primary care setting.Giseth Bustos, Marcos A Sanchez-Gonzalez, Troy Grogan, Adriana Bonansea-Frances, Camysha Wright
NPJ Primary Care Respiratory Medicine. 2024-08-01 - 1 citationsSigmoid volvulus in pregnancy: A rare case report.Alixandria F Pfeiffer, Reece E Clark, Jana Sullivan, Syed A A Rizvi, John J Byrne
International Journal of Gynaecology and Obstetrics. 2024-06-01 - Ferrer Adjustable Speaking Valve for Early Phonation in a Deconditioned Patient.Rafael Cartaya, Syed A A Rizvi, Viviane Manara, Mari L Tesch, Rahaghi Franck
Cureus. 2024-06-01
Journal Articles
- A Rare Case Report on Radiation Recall Pneumonitis in a Patient Treated with Durvalumab for Non-Small Cell Lung CancerSM Imam, F Haider, Syed AA Rizvi, Consultant, 12/12/2024
- Mitigating the risks of post-acute sequelae of SARS-CoV-2 infection (PASC) with intranasal chlorpheniramine: perspectives from the ACCROS studiesFernando Valerio-Pascua, Fernando Baires, Anupamjeet Kaur Sekhon, Mari L. Tesch, Estela Jackeline Pineda, Syed A. A. Rizvi, Jarmanjeet Singh, David Abraham Cortes-Band..., BMC Infectious Diseases, 11/26/2024
- Incretin mimetics for the management of diabetes and associated comorbidities: An overviewFaryal Haider, Syed M. Imam, Orien L. Tulp , Syed A. A. Rizvi, Innovative Medicines & Omics, 11/22/2024
- Join now to see all
Books/Book Chapters
Authored Content
- Drug Delivery Using NanomaterialsJanuary 2022
- Social Aspects of Drug Discovery, Development and CommercializationFebruary 2016
Press Mentions
- Separation by levitationApril 30th, 2022
Other Languages
- Hindi, Urdu
External Links
- Google Scholarhttps://scholar.google.com/citations?user=7DZNAncAAAAJ&hl=en
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: